These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy. Narayan R, Gadag S, Cheruku SP, Raichur AM, Day CM, Garg S, Manandhar S, Pai KSR, Suresh A, Mehta CH, Nayak Y, Kumar N, Nayak UY. Carbohydr Polym; 2021 Jun 01; 261():117893. PubMed ID: 33766378 [Abstract] [Full Text] [Related]
6. Fabrication of Chitosan-coated Mesoporous Silica Nanoparticles Bearing Rosuvastatin as a Drug Delivery System. Ghahfarokhi MR, Dini G, Movahedi B. Curr Drug Deliv; 2022 Jun 01; 19(1):64-73. PubMed ID: 34151762 [Abstract] [Full Text] [Related]
9. pH-Responsive Mesoporous Silica Nanoparticles Loaded with Naringin for Targeted Osteoclast Inhibition and Bone Regeneration. Gong S, Lang S, Wang Y, Li X, Tian A, Ma J, Ma X. Int J Nanomedicine; 2024 Jun 01; 19():6337-6358. PubMed ID: 38946884 [Abstract] [Full Text] [Related]
17. Dual-Functionalized Mesoporous Silica Nanoparticles for Celecoxib Delivery: Amine Grafting and Imidazolyl PEI Gatekeepers for Enhanced Loading and Controlled Release with Reduced Toxicity. Mudhakir D, Sadaqa E, Permana Z, Mumtazah JE, Zefrina NF, Xeliem JN, Hanum LF, Kurniati NF. Molecules; 2024 Jul 27; 29(15):. PubMed ID: 39124951 [Abstract] [Full Text] [Related]
18. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs. Li T, Geng T, Md A, Banerjee P, Wang B. Colloids Surf B Biointerfaces; 2019 Apr 01; 176():185-193. PubMed ID: 30616109 [Abstract] [Full Text] [Related]